Modified Trityl Protecting Groups for Oligonucleotide Purity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing and purifying oligonucleotides face challenges such as low coupling efficiency, incomplete removal of truncated sequences, and the need for harsh acids that can cause depurination, leading to impurities and reduced yields, especially in large-scale and high-purity applications.
Innovation Solution
The use of modified trityl protecting groups with selectively-reactive linker moieties that allow for mild deprotection and efficient capture and release of full-length oligonucleotides using complementary linker moieties, enabling high-purity synthesis and purification in aqueous media without toxic solvents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If solid-phase synthesis with standard trityl protecting groups is used, then oligonucleotide synthesis can proceed through multiple cycles, but coupling efficiency is limited to 99% and truncated sequences accumulate
Solution Approach 1:
The patent extracts and removes truncated sequences through selective binding to solid support. The 5'-hydroxyl groups of full-length oligonucleotides are selectively captured by the solid support while truncated sequences with 5'-phosphates remain in solution and are washed away, effectively separating the desired product from impurities
Solution Approach 2:
The patent introduces an intermediary solid support with 5'-hydroxyl binding capability that mediates the separation process. This solid support acts as a mediator to selectively capture full-length oligonucleotides, enabling efficient purification without requiring additional chemical modification of the oligonucleotides themselves
2Ease of manufacture
If harsh acids are used for deprotection, then trityl groups can be removed efficiently, but depurination occurs causing additional impurities
Solution Approach 1:
The patent changes the pH parameter of the deprotection process by using buffered solutions at controlled pH levels instead of harsh acids. This parameter change allows for effective trityl group removal while maintaining conditions that prevent depurination of purine bases in the oligonucleotide sequence
Solution Approach 2:
The patent converts the potentially harmful effect of acid exposure into a beneficial selective process. By carefully controlling acid exposure and using buffered conditions, the method achieves trityl removal while the solid support selectively captures full-length products, turning a source of impurities into a purification opportunity
3Manufacturing precision
If traditional purification methods are used, then truncated sequences can be removed, but the process is time-consuming and reduces overall yield
Solution Approach 1:
The patent merges the deprotection step with the purification step into a single integrated process. The solid support simultaneously serves as the medium for trityl group removal and as the capture medium for full-length oligonucleotides, eliminating the need for separate purification steps and significantly reducing processing time
4Ease of manufacture
If standard deprotection conditions are used, then trityl groups are removed, but the process requires harsh acids that are difficult to handle and dispose of
Solution Approach 1:
The patent changes the chemical parameters of the deprotection process by replacing harsh mineral acids with buffered aqueous solutions at controlled pH. This parameter change maintains deprotection effectiveness while eliminating the handling and disposal issues associated with concentrated strong acids, making the process safer and more environmentally friendly
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach increases yields, reduces costs, and enhances the scalability and purity of oligonucleotides, allowing for rapid production of high-quality biopolymers with improved efficiency and environmental sustainability.
Implementation Method 1
The differential purification strategy hinges on the presence of the trityl group on full-length oligonucleotides, as opposed to its absence on truncated failure sequences. The selectively-reactive linker moiety allows for efficient capture and release of full-length oligonucleotides using complementary linker moieties
Implementation Method 2
The differential purification process typically employs reversed-phase chromatographic techniques, where oligonucleotides with the trityl group are selectively adsorbed onto hydrophobic chromatographic media. This selective binding, driven by the hydrophobic nature of the trityl group, facilitates the separation of full-length oligonucleotides from truncated sequences
Implementation Method 3
The use of modified trityl protecting groups with selectively-reactive linker moieties that allow for mild deprotection and efficient capture and release of full-length oligonucleotides
Data Source
AI summary
The present disclosure provides reagent compounds, reactive biopolymeric compounds, and methods of making and using these materials for the rapid and efficient synthesis and purification of biopolymeric compounds at low cost. The materials and methods yield highly pure synthetic biopolymeric compounds, including synthetic oligonucleotides and polypeptides, and reduce or eliminate the need for toxic solvents in the synthetic process.